TX
TherapeuticsMD, Inc.
TXMD · NASDAQ
$2.19 +0.23% (+$0.01)
1M +5.80%
Market Cap $25.3M
P/E Ratio -
Div. Yield -
ROE 0.80%
Piotroski F-Score Moderate
4/9Valuation
79 /100
Cheap P/S 7.75x
P/B 0.93x
P/FCF 8.12x
Growth
0 /100
Declining Rev. growth 64.91%
Book val. growth 8.55%
EPS growth N/A
Profitability
50 /100
Moderate Gross margin 100.00%
Net margin 6.64%
Op. margin 118.20%
Quality
2 /100
Poor ROIC 12.92%
ROE 0.80%
ROA 0.58%
Debt
69 /100
Low Debt/Equity 0.20x
Current ratio 3.22x
Int. coverage -1,405.25x
Stability
56 /100
Moderate Beta 0.65x
Rev. volatility 89.38%
EPS volatility 10.76%
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre TXMD
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Marlan D. Walker
Employees
1
Headquarters
Boca Raton
Evenimente viitoare
17 NOV.
Earnings
Upcoming earnings report